Biogen Faces Challenges Amid Pipeline Setbacks and Sales Slowdown
Dec 9, 2024
Leqembi Invest Information
Eisai Submits LEQEMBI® (lecanemab-irmb) Biologics License Update to FDA for Early Alzheimer's Treatment – Biogen Stocks in Focus
Jun 10, 2024